Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2018 1
2019 1
2020 3
2021 2
2022 5
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Piccini JP, Caso V, Connolly SJ, Fox KAA, Oldgren J, Jones WS, Gorog DA, Durdil V, Viethen T, Neumann C, Mundl H, Patel MR; PACIFIC-AF Investigators. Piccini JP, et al. Lancet. 2022 Apr 9;399(10333):1383-1390. doi: 10.1016/S0140-6736(22)00456-1. Epub 2022 Apr 3. Lancet. 2022. PMID: 35385695 Clinical Trial.
SGLT2 Inhibitors and Their Antiarrhythmic Properties.
Kolesnik E, Scherr D, Rohrer U, Benedikt M, Manninger M, Sourij H, von Lewinski D. Kolesnik E, et al. Among authors: rohrer u. Int J Mol Sci. 2022 Jan 31;23(3):1678. doi: 10.3390/ijms23031678. Int J Mol Sci. 2022. PMID: 35163599 Free PMC article. Review.
Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) - A phase III study.
von Lewinski D, Tripolt NJ, Sourij H, Pferschy PN, Oulhaj A, Alber H, Gwechenberger M, Martinek M, Seidl S, Moertl D, Nürnberg M, Roithinger FX, Steinwender C, Stühlinger M, Zirlik A, Benedikt M, Kolesnik E, Wallner M, Rohrer U, Manninger M, Scherr D; ERASe study group. von Lewinski D, et al. Among authors: rohrer u. Am Heart J. 2022 Apr;246:152-160. doi: 10.1016/j.ahj.2022.01.008. Epub 2022 Jan 16. Am Heart J. 2022. PMID: 35045327 Free article. Clinical Trial.
PRospective REgistry of PAtients in REfractory cardiogenic shock-The PREPARE CardShock registry.
von Lewinski D, Herold L, Stoffel C, Pätzold S, Fruhwald F, Altmanninger-Sock S, Kolesnik E, Wallner M, Rainer P, Bugger H, Verheyen N, Rohrer U, Manninger-Wünscher M, Scherr D, Renz D, Yates A, Zirlik A, Toth GG. von Lewinski D, et al. Among authors: rohrer u. Catheter Cardiovasc Interv. 2022 Sep;100(3):319-327. doi: 10.1002/ccd.30327. Epub 2022 Jul 13. Catheter Cardiovasc Interv. 2022. PMID: 35830719 Free PMC article.
Assessing the weak links - Necessity and impact of regional cardiac arrest awareness campaigns for laypersons.
Orlob S, Grundner S, Wittig J, Eichinger M, Pucher F, Eichlseder M, Lingitz R, Rief M, Palt N, Hartwig C, Zangl G, Haar M, Manninger M, Rohrer U, Scherr D, Zirlik A, Prause G, Zweiker D. Orlob S, et al. Among authors: rohrer u. Resusc Plus. 2023 Jan 6;13:100352. doi: 10.1016/j.resplu.2022.100352. eCollection 2023 Mar. Resusc Plus. 2023. PMID: 36654724 Free PMC article.
No antiarrhythmic effect of direct oral anticoagulants versus vitamin K antagonists in paroxysmal atrial fibrillation patients undergoing catheter ablation.
Zweiker D, Manninger M, Sieghartsleitner R, Ebner J, Pratl B, Bisping E, Lercher P, von Lewinski D, Riedlbauer R, Rohrer U, Spronk HMH, Zirlik A, Schotten U, Scherr D. Zweiker D, et al. Among authors: rohrer u. Int J Cardiol. 2021 May 15;331:106-108. doi: 10.1016/j.ijcard.2021.01.003. Epub 2021 Jan 26. Int J Cardiol. 2021. PMID: 33508338
19 results